ããçŒããèãâå®ããèâã«å€ããïœå èå察çã®å çã¢ãããŒã
ãæ¥çŒãæ¢ããå¡ã£ãŠããã®ã«ããªããèªåã ãããèµ€ããªãã»é»ããªãã ãæ¥å·®ãã«åŒ±ãäœè³ªã¯ãçãŸãã€ãã§å€ããããªãã®ã§ã¯ïŒã
ããããçåãæã€äººã¯å°ãªããããŸãããå®éãæ¥çŒãäœè³ªã®çŽ50ã70ïŒ ã¯éºäŒçèŠå ã«å·Šå³ããããšãããç®èã®è²ã»ã¡ã©ãã³çæã®é床ã»é žåã¹ãã¬ã¹èæ§ã¯ãåã ã®éºäŒåãããã¡ã€ã«ã«ãã£ãŠå€§ããç°ãªããŸãããããåæã«ãèã®å èåã¯çæŽ»ç¿æ £ã»æ 逿åã»ä»£è¬ç°å¢ã«ãã£ãŠåŸå€©çã«å€§ããå€ããããéšåã§ããããŸãã
æ¬èšäºã§ã¯ããéºäŒåãšå èåã®ç§åŠãã軞ã«ããªããã**å€åŽããå®ãïŒã¹ãã³ã±ã¢ã»æ¥çŒãæ¢ãïŒã ãã«é Œããªãâå çã¢ãããŒãâ**ã培åºè§£èª¬ããŸããéºäŒåã«èå³ãããèªè ãå°éå®¶ã®æ¹ã«ãååèªã¿å¿ãã®ããå 容ãç®æããŠããŸãã
ã¡ã©ãã³çæãšå èåã®åºæ¬ã¡ã«ããºã
玫å€ç·ïŒUVA/UVBïŒãç®èã«å°éãããšããŸãDNAãæå·ãã现èã¯ç·æ¥å¯ŸåŠãšããŠã¡ã©ããµã€ããæŽ»æ§åããŸããè€è²ã¡ã©ãã³ïŒãŠãŒã¡ã©ãã³ïŒãå€ãã»ã©å é²åŸ¡åã¯é«ãŸããäžæ¹ã§èµ€ã£ãœããã§ãªã¡ã©ãã³ãå€ã人ã¯å é²åŸ¡ã匱ããççããããäœè³ªã«ãªããŸãã
ã»UVBã¯DNAã«çŽæ¥æå·ïŒCPDïŒãäžãã ã»UVAã¯æ·±éšã®çç®ã«å±ããã³ã©ãŒã²ã³ç Žå£ãä¿é² ã»æŽ»æ§é žçŽ ïŒROSïŒã倧éçºçããççã»è²çŽ æ²çã»èåãå é
éºäŒåç ç©¶ã§ã¯ããããã®çŽ«å€ç·åå¿ã®éããMC1RãTYRãSOD2ãGPX1ãªã©ã®éºäŒåå€åã«ãã£ãŠå€§ããå€ããããšã瀺ãããŠããŸãã
ïŒåèïŒMC1RãšçŽ«å€ç·å¿çãhttps://pubmed.ncbi.nlm.nih.gov/20335613/ïŒ
ããæ¥çŒãããäœè³ªãã€ããéºäŒçèŠå
MC1RïŒã¡ã©ãã³ã«ãã³1å容äœïŒ
èµ€æ¯ã®äººã«å€ãå€ç°ã§ç¥ãããŸãããã¢ãžã¢äººã§ãç¹å®ã®å€åãæã€ãš ã»æ¥çŒãã§èµ€ããªã ã»é»ããªãã«ãã ã»å èåãé²ã¿ããã ãšãã£ãç¹åŸŽã«ã€ãªããããšãæããã«ãªã£ãŠããŸãã
TYR / TYRP1ïŒããã·ããŒãŒéºäŒåïŒ
ã¡ã©ãã³åæé µçŽ ãé žåã¹ãã¬ã¹ãé«ããšããããã®é µçŽ æŽ»æ§ã¯äœäžããŸãã
æé žåç³»éºäŒåïŒSOD2 / GPX1 / CATïŒ
ããã匱ã人ã¯ãROSåŠçèœåãäœããUVã«ããççãã¡ãŒãžãèç©ããããäœè³ªã§ãã
ïŒåèïŒæŽ»æ§é žçŽ åŠçãšç®èèåã®é¢é£ãhttps://pubmed.ncbi.nlm.nih.gov/26126088/ïŒ
å èåãåŒãèµ·ããâèŠããªãççâ
å èåã¯ã·ã³ãã«ã«èªãããã¡ã§ããããã®æ¬è³ªã¯æ ¢æ§ççã«ãããŸãã
- 玫å€ç· â ROS倧éçºç
- ROSãDNAã»è質ã»ã¿ã³ãã¯è³ªãæ»æ
- NF-κBãæŽ»æ§å
- IL-1βãIL-6ãªã©ççæ§ãµã€ãã«ã€ã³å¢å
- ã¡ã©ããµã€ãéå°åºæ¿ â ã·ã
- ã³ã©ãŒã²ã³åè§£ â ã·ã¯ã»ããã¿
å®éã玫å€ç·ãã¡ãŒãžã®80ïŒ ä»¥äžã¯æŽ»æ§é žçŽ ã«ããé žåãã¡ãŒãžãå å¶ã ãšå ±åãããŠããŸãã
ïŒåèïŒUVèªå°æ§é žåã¹ãã¬ã¹ãšç®èèåãhttps://pubmed.ncbi.nlm.nih.gov/17935605/ïŒ
å çã¢ãããŒãâ æé žåæ é€çŽ ã§ROSãæ ¹æ¬å¶åŸ¡ãã
å èåã®å€§åãROSã«ãããã®ã§ãã以äžãäœå ã§æé žååãé«ããããšãæéèŠã§ãã
â ãã¿ãã³C
ã»ã¡ã©ãã³æå¶ ã»ã³ã©ãŒã²ã³çæä¿é² ã»SOD/GPXã®åããè£å© UVãã¡ãŒãžã®è»œæžå¹æã¯å€ãã®èšåºç ç©¶ã§ç¢ºèªãããŠããŸãã
ïŒåèïŒãã¿ãã³CãšçŽ«å€ç·ä¿è·ãhttps://pubmed.ncbi.nlm.nih.gov/16307757/ïŒ
â ãã¿ãã³EïŒãã³ãã§ããŒã«ïŒ
èè³ªé žåãæãã现èèãä¿è·ããã¿ãã³Cãšäœµçšããããšã§çžä¹å¹æã
â ããªãã§ããŒã«
ã¬ã¹ãã©ãããŒã«ãã«ã«ãªããªãã§ããŒã«ãã¢ã³ãã·ã¢ãã³ãªã©ã¯ ã»æçç ã»æé žå ã»ã¡ã©ããµã€ãéæŽ»æ§ã®æå¶ ã«åªããå èåæ¹åã®ããŒã¿ãè±å¯ã§ãã
å çã¢ãããŒãâ¡ ããã³ã³ããªã¢æŽ»æ§ãšNrf2çµè·¯ã匷åãã
è¿å¹Žã®ç®èç§åŠã§ã¯ãããã³ã³ããªã¢æ©èœïŒèã®èä¹ åãšããæ§å³ãæç¢ºã«ãªã£ãŠããŸãã
ããã³ã³ããªã¢ã匱ããš ã»ãšãã«ã®ãŒäžè¶³ ã»ä¿®åŸ©äžèœãªçްèå¢å ã»ççã®æ ¢æ§å ã»å èåå é ã«ã€ãªãããŸãã
â Nrf2ãæŽ»æ§åããæ é€çŽ
代衚äŸïŒã¹ã«ãã©ã©ãã¡ã³ãã±ã«ã»ãã³ããã¹ããªã³é ž Nrf2ã¯æé žåé µçŽ ããŸãšããŠæŽ»æ§åããâãã¹ã¿ãŒã¹ã€ããâã§ãããå èåé åã®ç ç©¶ã§ã泚ç®ãããŠããŸãã
ïŒåèïŒNrf2ãšçŽ«å€ç·ä¿è·ãhttps://pubmed.ncbi.nlm.nih.gov/26709791/ïŒ
å çã¢ãããŒã⢠现èèã®åŒ·ãïŒæ¥çŒããã«ãã
现èèã¯è質ã§ã§ããŠãããããèèªé žã®è³ªããã®ãŸãŸãççã®èµ·ãããããããæ±ºããŸãã
â ãªã¡ã¬3èèªé žïŒEPA/DHAïŒ
ã»ççæ§ãµã€ãã«ã€ã³ã®æå¶ ã»çްèèãæè»ã«ä¿ã€ ã»UVBèªå°ççã®è»œæž
ïŒåèïŒãªã¡ã¬3ãšç®èççãhttps://pubmed.ncbi.nlm.nih.gov/29507625/ïŒ
â ãªã¡ã¬6éå°ã¯NG
ãªã¡ã¬6ãå€ããšã¢ã©ããã³é žä»£è¬ãåªäœã«ãªããççæ§ç©è³ªãå¢ããŠæ¥çŒããã¡ãŒãžãå¢å¹ ããŸãã
ãã©ã³ã¹ãéµãšãªããŸãã
å çã¢ãããŒãâ£ è žå ç°å¢ãšç®èå ç«ã®é¢ä¿
ç®èãšè žã¯å¯æ¥ã«ã€ãªãã£ãŠãããè žå 现èå¢ã®ä¹±ã㯠ã»ççæ§ãµã€ãã«ã€ã³ã®å¢å ã»å ç«åå¿ã®èª€äœå ã»ç®èããªã¢ã®è匱å ã«ã€ãªãããŸãã
ç ç©¶ã§ã¯ãç¹å®ãããã€ãªãã£ã¯ã¹ã玫å€ç·ãã¡ãŒãžã«å¯Ÿããæµææ§ãé«ããå¯èœæ§ã瀺ãããŠããŸãã
ïŒåèïŒè ž-ç®è軞ãšå èåãhttps://pubmed.ncbi.nlm.nih.gov/34345430/ïŒ
å çã¢ãããŒãâ€ å æåUVã±ã¢æåã®ãšããã³ã¹
â ããªããã£ãŠã ãã€ã³ãã¢ã¹ïŒPLãšãã¹ïŒ
ã»UVBã«ããçŽ æã®è»œæž ã»ã¡ã©ãã³çæã®æå¶ ã»DNAæå·ã®æžå° è€æ°ã®èšåºç ç©¶ã§å¹æã瀺ãããŠããŸãã
ïŒåèïŒPolypodium leucotomosãhttps://pubmed.ncbi.nlm.nih.gov/19461221/ïŒ
â ã¢ã¹ã¿ããµã³ãã³
ã»åŒ·åãªæé žåäœçš ã»èè³ªé žåã®æå¶ ã»ã·ã¯æ¹å å èåé åã§æãç ç©¶ãããã«ãããã€ãã®ã²ãšã€ã
â NutroxSunïŒã·ãã©ã¹ïŒããŒãºããªãŒïŒ
ã»UVA/UVBãã¡ãŒãžã®è»œæž ã»ã·ãæå¶ ã»èã®æ°Žåéæ¹å æ¬§å·ãäžå¿ã«èšåºããŒã¿ãå¢å äžã
éºäŒåæ€æ»ã«ããâæ¬åœã®åŒ±ç¹âã®ç¹å®
å èå察çã¯ãã©ã®éºäŒåã匱ãããã§æŠç¥ãå€ãããŸãã
â MC1Rã匱ã â ã¡ã©ãã³çæã®å¹çãæªã
â ãã¿ãã³Cã»é ã»ããã·ã³ã®ãµããŒããå¿ é
â æé žåé µçŽ ïŒSOD/GPXïŒã匱ã
â ããªãã§ããŒã«ã»Nrf2ç³»ãµããªã®åŒ·åãæå¹
â ççéºäŒåïŒTNF-α / IL-6ïŒãé«åå¿
â ãªã¡ã¬3ã§ççãããã¡ã€ã«ãæ¯æ£
éºäŒåæ å ±ãç¥ãããšã§ããã æ¥çŒãæ¢ããå¡ãã®ã§ã¯ãªã ãèªåã«å¿ èŠãªâå åŽã®ã±ã¢âãæ£ç¢ºã«ãããã ãšãã倧ããªã¡ãªããããããŸãã
èãâå®ããèâã«å€ããããã®å®è·µæŠç¥ïŒç·æ¬ïŒ
ãããŸã§ã®ç§åŠçç¥èŠãããšã«æŽçãããšã次ã®5ã€ãâå®ããèâã®æ¡ä»¶ã§ãã
- 玫å€ç·ã§çããROSãçŽ æ©ãåŠçã§ããæé žåå
- ã¡ã©ãã³çæãé©åã«ã³ã³ãããŒã«ã§ãã代è¬ç°å¢
- ççãå¿ èŠä»¥äžã«èµ·ãããªãè質ãããã¡ã€ã«
- ããã³ã³ããªã¢ããã£ãããšãã«ã®ãŒãäœããç¶æ
- è žå ç°å¢ãå®å®ããç®èå ç«ãéå°åå¿ããªãããš
ããã¯å€åŽã®ã±ã¢ã ãã§ã¯çµ¶å¯Ÿã«éæã§ããŸããã å åŽã®äœè³ªã¥ããããããé·æçã«èŠãŠæã倧ããªå·®ãçã¿ãŸãã
å èå察çã«ãããâéºäŒåãããã¯ãŒã¯âã®æãæ¹
æ¥çŒãããããã¯ãåäžéºäŒåã§ã¯èª¬æã§ããŸãããè¿å¹Žã®ã²ãã ç ç©¶ã§ã¯ãå èåã¯è€æ°ã®éºäŒåãé£éçã«åããç°å¢å åïŒçŽ«å€ç·ã»æ é€ã»ãã«ã¢ã³ã»ç¡ç ïŒãšçžäºäœçšããªããé²è¡ããè€åçŸè±¡ã§ããããšã瀺ãããŠããŸãã
ç¹ã«éèŠãªã®ã¯ã以äžã®ã4倧ãããã¯ãŒã¯ãã§ãã
â1. ã¡ã©ãã³åæãããã¯ãŒã¯
MC1RãTYRãTYRP1ã¯äžå¿çéºäŒåã§ãããå®éã«ã¯ ã»MITF ã»OCA2 ã»SLC24A5 ãªã©ãé¢äžããŠãããã¡ã©ããµã€ãã®æŽ»æ§ã¯éåžžã«è€éã§ãã
â2. æé žåã¹ãã¬ã¹ãããã¯ãŒã¯
SOD2ãGPX1ãCATãPRDXãã¡ããªãŒãªã©ãROSåŠçã®äž»è»žã ãããã匱ãäœè³ªã®äººã¯ãUVæé²åŸã®ççãé·æéç¶ããããåŸåããããŸãã
â3. ççå¿çãããã¯ãŒã¯
TNF-αãIL-1βãIL-6ãCOX-2ãªã©ã éå°åå¿æ§ã®äœè³ªã¯ã玫å€ç·ã®ãã¡ãŒãžãâå¿ èŠä»¥äžã«å¢å¹ âãããŸãã
â4. ç®èããªã¢ã»æå·ä¿®åŸ©ãããã¯ãŒã¯
FLGïŒãã£ã©ã°ãªã³ïŒãAQP3ãCOL1A1ãMMP1ãMMP3ãªã©ã ç®èã®ä¿®åŸ©èœåã«ãéºäŒåæ§ããããŸãã
ãã®4é åãçè§£ãããšãå èåã¯åãªãã玫å€ç·ã®åé¡ãã§ã¯ãªããäœã®å éšç°å¢ã®åé¡ã§ãããããšãããããŸãã
âèµ€ããªã人ã»ããé»ããªã人âã®éºäŒåã¬ãã«ã®éã
äžè¬çã«ã ã»èµ€ããªã人 â ççã»DNAæå·ã匷ã ã»é»ããªã人 â ã¡ã©ãã³çæãçŽ æ©ããå é²åŸ¡ã¯æ¯èŒç匷ã ãšæããããŸãããå®éã«ã¯ãã£ãšæ·±ãã¡ã«ããºã ããããŸãã
âèµ€ããªã人ã®ç¹åŸŽ
ã»MC1Rã®æ©èœäœäž ã»ãã§ãªã¡ã©ãã³ã®æ¯çãé«ã ã»æé žåé µçŽ æŽ»æ§ã匱ãã±ãŒã¹ãå€ã ã»ç®èã®p53å¿çãéæã§ççãèµ·ããããã
âé»ããªã人ã®ç¹åŸŽ
ã»ãŠãŒã¡ã©ãã³ã®çæãæŽ»çº ã»DNAæå·ã®ä¿®åŸ©ã¹ããŒããéã ã»ããã³ã³ããªã¢æ©èœãæ¯èŒç匷ã ã»ç®èããªã¢ãåã
èµ€ããªãäœè³ªã¯ãå é²åŸ¡ã®ã¹ã¿ãŒãå°ç¹ãäœãã ãã§ãªããççãé·åŒãããèåã®é床ãéããšãã倧ããªèª²é¡ãæ±ããŠããŸãã
å èåãå éãããâ现èå ã®æ§é å€åâ
玫å€ç·ã¯è¡šé¢ã®èè²å€åã ãã§ã¯ãªãã现èå éšã§æ¬¡ã®ãããªå€åãåŒãèµ·ãããŸãã
ââ ããã³ã³ããªã¢DNAïŒmtDNAïŒã®æå·
mtDNAã¯æ žDNAããã修埩èœåã匱ãã玫å€ç·ã«ãã£ãŠæå·ããããæ§é ã§ãã mtDNAãå·ã€ããšã ã»ãšãã«ã®ãŒç£çäœäž ã»ROSå¢å ã»çŽ°èæ»ã®èªå° ãèµ·ãããå èåãå éããŸãã
â⡠现èèè質ã®é žå
玫å€ç·ã«ããè質ãé žåãããšãèã®æµåæ§ãäœäžããççæ§ç©è³ªïŒ4-HNEãªã©ïŒãçãŸããŸãã ããã¯åšå²ã®çްèã«ãåºãããççãâé£éæ¡å€§âãããŸãã
â⢠ã³ã©ãŒã²ã³åè§£é µçŽ ïŒMMPïŒã®æŽ»æ§å
ç¹ã«UVAã¯MMP-1ãMMP-3ãæŽ»æ§åããçç®æ§é ãç Žå£ããŸãã ã³ã©ãŒã²ã³ãæžå°ããã·ã¯ã»ããã¿ãèµ·ãããŸãã
â⣠ãšããžã§ããã£ãã¯å€å
玫å€ç·ã¯DNAã¡ãã«åãã¿ãŒã³ãå€åããã ã»èåé¢é£éºäŒåã®çºçŸäžæ ã»ä¿®åŸ©éºäŒåã®çºçŸäœäž ãåŒãèµ·ããããšãå ±åãããŠããŸãã
ã€ãŸããå èåã¯ãçŽ°èæŽ»åã®èåãã§ããããããå åŽããç«ãŠçŽãããšãéåžžã«å¹æçãªã®ã§ãã
æé žåã¢ãããŒããâæŠç¥çã«âåæ§ç¯ãã
æé žåãšäžå£ã«èšã£ãŠããæ é€çŽ ããšã«äœçšã¬ãã«ãç°ãªããŸãã å èå察çã«ã¯ã以äžã®3éå±€ãæèãããšå¹æãæå€§åããŸãã
ã第äžéå±€ãçŽæ¥çãªROSé€å»ïŒå³æé²åŸ¡ïŒ
ãã¿ãã³Cããã¿ãã³Eãã°ã«ã¿ããªã³ãã¢ã³ãã·ã¢ãã³ããªã³ãã³ãªã©ã
ã»UVç §å°çŽåŸã®ççæå¶ ã»DNAæå·ã®æžå° ã»èè³ªé žåã®æå¶
æé žåç©è³ªã®âæ¶èãæ©ãâãããããŸããªæåãéµãšãªããŸãã
ã第äºéå±€ãæé žåé µçŽ ãæŽ»æ§åïŒæç¶é²åŸ¡ïŒ
Nrf2ãåºæ¿ããæåãããã«è©²åœããŸãã
ã»ã¹ã«ãã©ã©ãã¡ã³ ã»ã±ã«ã»ãã³ ã»ãã¹ããªã³é ž ã»ã«ããã³ïŒEGCGïŒ ã»ã¯ã«ã¯ãã³
ãããã¯âäœå ã®æé žååãåºäžãâãããããUV察çã®äžæ žãšããŠæãéèŠãã¹ãé åã§ãã
ã第äžéå±€ãçŽ°èæ§é ã匷åïŒæ§é é²åŸ¡ïŒ
现èãã®ãã®ã玫å€ç·ã«åŒ·ãããã¢ãããŒãã
â 现èè匷åïŒãªã¡ã¬3
EPAã»DHAã¯çްèèãæè»ã«ããççæ§ç©è³ªã®æŽèµ°ãæããŸãã
â ããã³ã³ããªã¢åŒ·åïŒCoQ10ã»PQQ
ãšãã«ã®ãŒç£çã®è³ªãé«ãã玫å€ç·ãã¡ãŒãžåŸã®ä¿®åŸ©é床ãåäžãããŸãã
â ããªã¢åŒ·åïŒã»ã©ããã»ããªãã³ã»äºé
ç®èããªã¢ã匷ãã»ã©ãå èåã®åœ±é¿ã¯å°ãªããªããŸãã
ãã«ã¢ã³ç°å¢ãšå èåã®é¢ä¿ïŒèŠèœãšãããã¡ãªèŠå
玫å€ç·æåæ§ã¯ããã«ã¢ã³ãã©ã³ã¹ãšã坿¥ã«é¢ãã£ãŠããŸãã
âãšã¹ããã²ã³äœäž
ã»ã³ã©ãŒã²ã³æžå° ã»ç®èåæ³äœäž ã»ä¹Ÿç¥ã«ããççå¢å æŽå¹ŽæååŸã®å¥³æ§ãæ¥çŒããã¡ãŒãžãåãããããªãã®ã¯ãããçç±ã§ãã
âã³ã«ããŸãŒã«ïŒã¹ãã¬ã¹ãã«ã¢ã³ïŒ
æ ¢æ§ã¹ãã¬ã¹ã¯ ã»æé žååã®äœäž ã»å ç«äœäž ã»ç®è修埩ã®é å»¶ ãåŒãèµ·ããããã玫å€ç·èæ§ãèœã¡ãŸãã
âç²ç¶è ºãã«ã¢ã³
äœäžãããšç®èã®ã¿ãŒã³ãªãŒããŒãé ããã¡ã©ãã³èç©ãå¢ããŸãã
ãã«ã¢ã³ã®èæ¯ãŸã§èæ ®ãããšãå èåã¯âå šèº«æ§ã®åé¡âã§ããããšãçè§£ã§ããŸãã
å èåã«åŒ·ããªãããã®é£äºæŠç¥
å çã¢ãããŒãã®å®è·µã¯ãé£äºå å®¹ã®æ¹åããå§ãŸããŸãã 以äžã¯éºäŒåã¿ã€ãã«é¢ä¿ãªããå€ãã®äººã«å¹æãããæ¹æ³ã§ãã
â1. ã«ãããã€ãæåã®æé©å
ã»ãªã³ãã³ïŒãããïŒ ã»Î²ã«ããã³ïŒãã³ãžã³ã»ã»ãããèïŒ ã»ã«ãã€ã³ã»ãŒã¢ããµã³ãã³ïŒã±ãŒã«ïŒ
èæº¶æ§ãªã®ã§ããªãªãŒããªã€ã«ãšäžç·ã«æåãããšåžåãå¢å ããŸãã
â2. ããªãã§ããŒã«ã®å€ãæç©ã»è¶
ã»ãã«ãŒããªãŒ ã»ã«ã«ãª ã»ç·è¶ ã»ããŒãºããªãŒ æé žåÃæççÃDNAä¿è·ã®äžæåãæã£ãŠããŸãã
â3. è¯è³ªãªè質ãçµã¿èŸŒã
ã»ãªã¡ã¬3ïŒééãäºéº»ä»æ²¹ããã㟠ã»ãªãªãŒããªã€ã«ïŒãªã¬ã€ã³é žãççãæãã
ãªã¡ã¬6ã®å€ãé£äºïŒæãç©ã»ã¹ããã¯ã»å å·¥é£åïŒã¯é广ãªã®ã§æ³šæã
â4. ç®èã®åºç€âã³ã©ãŒã²ã³âã®çŽ æãæã
ã»ã³ã©ãŒã²ã³ãããã ã»äºé ã»ãããªã³ã»ãªãžã³ ã»ãã¿ãã³C
å åŽã®ææããªããã°èã¯ä¿®åŸ©ã§ããŸããã
â5. è žå ç°å¢ãæŽãã飿
ã»çºé µé£åïŒå³åãçŽè±ããã ãïŒ ã»é£ç©ç¹ç¶ïŒæµ·è»ããªãŒãããŒã«ïŒ ã»ããªãã§ããŒã«ïŒè žå 现èã®é€ã«ãªãïŒ
è žãæŽããšççãèœã¡çããèã®èä¹ åãäžãããŸãã
âå®ããèâãã€ããçæŽ»ç¿æ £èšèš
é£äºã ãã§ãªããçæŽ»ç¿æ £ãéèŠã§ãã
âååãªç¡ç
ç¡ç äžã«DNAä¿®åŸ©é µçŽ ãæŽ»æ§åããŸããç¡ç äžè¶³ã¯å èåã®æå€§ã®ãªã¹ã¯èŠå ã®ã²ãšã€ã§ãã
âè¡ç³ã³ã³ãããŒã«
è¡ç³å€ã®ä¹±é«äžã¯ççãæããAGEsãã³ã©ãŒã²ã³ãç Žå£ããŸãã
âå ¥æµŽã»ãµãŠã
è¡è¡æ¹åã¯çްèã®ä¿®åŸ©é床ãäžããŸãããéå°ãªç±ã¹ãã¬ã¹ã¯é广ãªã®ã§æ³šæã
âéå
ããã³ã³ããªã¢ãå¢ããæã確å®ãªçæŽ»ç¿æ £ã é±150åã®äžåŒ·åºŠéåãæšå¥šã©ã€ã³ã§ãã
âçŠç
ã¿ãã³ã¯ã³ã©ãŒã²ã³ç Žå£ã»èåä¿é²ã»è¡è¡äžè¯ã®äžéãã¡ãŒãžã å èå察çã«ãããŠã¯å¿ é ã®è¡åã§ãã
éºäŒåÃååæ é€åŠã«ããâå奿é©åâã®å¯èœæ§
ä»åŸã®å èå察çã¯ããéºäŒåæ€æ»ïŒæ é€è§£æãã§æé©åããŠããæä»£ã«ãªããŸãã
äŸãšããŠâŠ
âMC1Rã«åŒ±ãããã人
â ããã·ã³ãé ããã¿ãã³Cã匷å
âSOD2ã匱ã人
â ãã³ã¬ã³ãããªãã§ããŒã«ãNrf2æŽ»æ§æå
âGPX1ã匱ã人
â ã»ã¬ã³ããã¿ãã³E
âççéºäŒåã匷ãåå¿ãã人
â ãªã¡ã¬3ãæççããªãã§ããŒã«
âç®èããªã¢éºäŒåã«èª²é¡
â ã»ã©ãããããªãã³ãäºé
éºäŒååã«åãããã¢ãããŒãã¯ãåã玫å€ç·ã济ã³ãŠããã¡ãŒãžãâæå°åã§ããâäœè³ªã¥ãããå®çŸããŸãã
æªæ¥ã®å èå察çïŒAIÃéºäŒåÃ代è¬è§£æ
çŸåšãç®èç§åŠã§ã¯æ¬¡ã®é åãæ¥éã«é²ãã§ããŸãã
âAIã«ãã玫å€ç·ãã¡ãŒãžäºæž¬
èç»åè§£æã«ãã£ãŠãå人ã®å èåãªã¹ã¯ãäºæž¬ããæè¡ãæ®åäžã
âéºäŒåÃè žå 现èå¢Ã代è¬ç©ã®çµ±åè§£æ
æ¥çŒãããããããè žå 代è¬ç©ïŒçéèèªé žãããªã¢ãã³ãªã©ïŒãšé¢é£ããããšãããã£ãŠããŠããŸãã
âããŒãœãã«UVã±ã¢ã®æ¬æ Œå
ã»éºäŒå ã»ãã«ã¢ã³ ã»é£äº ã»è žå 现è ã»ã©ã€ãã¹ã¿ã€ã« ããããçµ±åããŠãåå¥UVã±ã¢ããã°ã©ã ããäœãããæªæ¥ã¯ç®åã§ãã
å èåã®é²è¡ã決ããâ现è幎霢âãšããèŠç¹
èã®èåãæãæ ¹æ¬ããæããæ¹æ³ã¯ãå®å¹Žéœ¢ã§ã¯ãªã**现è幎霢ïŒCellular AgeïŒ**ãè©äŸ¡ããããšã§ããå èåãå éããŠãã人ã¯ããã®çްè幎霢ãå®å¹Žéœ¢ããå€§å¹ ã«äžãã£ãŠããŸãã
现è幎霢ãäžããèŠå ã¯ä»¥äžã®éãã§ãïŒ
âããã¡ã¢ççž®
玫å€ç·ã¯ããã¡ã¢ççž®ãä¿é²ãã现è寿åœãçž®ããŸãã ãŸããæ ¢æ§çãªççïŒIn-flammagingïŒãããã¡ã¢ãæ»æããŸãã
âãµã€ã¬ã³ãççïŒåŸ®å°ççïŒ
è¡æ¶²æ€æ»ã§ã¯ç°åžžãåºãªãã¬ãã«ã§ãããç®èã®æ·±å±€ã§åžžã«èµ·ãã£ãŠããâäœã¬ãã«ççâãèåãå éãããŸãã
âããã³ã³ããªã¢ã®è³ªäœäž
ãæ°ãã質ããéèŠã§ãATPç£çãäœäžããããã³ã³ããªã¢ãå¢ãããšã玫å€ç·ããã®å埩åãäœäžããŸãã
å èåãé転ãããã«ã¯ããã®çްè幎霢ãè¥è¿ãããã¢ãããŒããäžå¯æ¬ ã§ãã
å èåãé ãããâãšããžã§ããã£ãã¯åæ§ç¯âãšããæ°ã¢ãããŒã
玫å€ç·ãåŒãèµ·ããæãèŠéãããã¡ãªãã¡ãŒãžã¯ã DNAé åãã®ãã®ã§ã¯ãªããéºäŒåã®ON/OFFãæ±ºãããšããžã§ããã£ãã¯å€åã§ãã
ç¹ã«çŽ«å€ç·ã¯ä»¥äžãåŒãèµ·ãããŸãïŒ
âDNAã¡ãã«åã®äœäž
èåéºäŒåïŒMMPãççéºäŒåïŒã掻æ§åãããããªãã
âãã¹ãã³ä¿®é£Ÿã®å€å
ã³ã©ãŒã²ã³åæéºäŒåã®çºçŸãäœäžã
âæé žåéºäŒå矀ïŒSOD2, GPX1, CATïŒã®æå¶
玫å€ç·ã«ããããããã³ã«ãé žåã¹ãã¬ã¹èæ§ã匱ãŸã£ãŠããã
ãã®ãšããžã§ããã£ãã¯ãªâ厩ãâãæ»ãã«ã¯ãNrf2掻æ§åæåãããªãã§ããŒã«ïŒã¬ã¹ãã©ãããŒã«ããã¹ããªã³é žãã±ã«ã»ãã³ïŒãªã©ãç¹ã«æå¹ã§ãããããã¯éºäŒåã¹ã€ãããå調æŽãã玫å€ç·ã«åŒ·ã现è衚çŸåãã€ãããŸãã
çç®ã®â现èå€ãããªãã¯ã¹ïŒECMïŒâãå®ãããšãå èå察çã®æçµã©ã€ã³
èã®ããªã»åŒŸåãæ±ºããã®ã¯ãã³ã©ãŒã²ã³ã ãã§ã¯ãããŸããã ECMã«ã¯ä»¥äžã®èŠçŽ ãå«ãŸããŸãïŒ
ã»ã³ã©ãŒã²ã³ ã»ãšã©ã¹ãã³ ã»ãã¢ã«ãã³é ž ã»ãã£ãããã¯ãã³ ã»ããããªã°ãªã«ã³
玫å€ç·ãã¡ãŒãžãèç©ãããšããã®ECMå šäœãå£åããŸãã ãšãã«UVAã¯çç®æ·±å±€ãŸã§å°éãã以äžã®å€åãçã¿ãŸãïŒ
âMMPïŒã³ã©ãŒã²ã³åè§£é µçŽ ïŒã®æåžžç掻æ§å
MMP-1ãMMP-3ãMMP-9ãå¢å ããçç®æ§é ãç Žå£ããŸãã
âç·ç¶èœçްèïŒFibroblastïŒã®èå
ç·ç¶èœçްèãç²åŒãããšãæ°ããã³ã©ãŒã²ã³ãäœãããªããªãã
âç³åïŒAGEsïŒãšã®çžä¹å¹æ
玫å€ç·ã¯ç³åãå éãããã³ã©ãŒã²ã³ç·ç¶ã硬ãèããªããŸãã
ããã«å¯Ÿæããã«ã¯ã ãã³ã©ãŒã²ã³ã®è£å ããšãåè§£æå¶ããåæã«è¡ãããš ããã€ã³ããšãªããŸãã
å ·äœçã«ã¯ã ã»ã³ã©ãŒã²ã³ãããã ã»ãã¿ãã³C ã»äºé ã»ããªãã§ããŒã«ïŒç¹ã«EGCGïŒ ãªã©ãéèŠã§ãã
ãŸããå èåãé²ãã§ãã人ã»ã©ãCoQ10ãPQQãã¢ã¹ã¿ããµã³ãã³ãªã©ã®ããã³ã³ããªã¢è£å©æåã®å¹æã倧ãããªããŸãã
âçŒããããèâãæãåºãããã«ã¯ãæ¥åžžã®ããå°ããªç¿æ £ãéµãæ¡ã
ãäœè³ªãå€ããããšãããšé£ããèãããŸãããå®éã«ã¯çްèã®ä¿®åŸ©ãšé²åŸ¡ã®æ¡ä»¶ãæŽããã°ãèã¯ç¢ºå®ã«å€ãããŸããå°éå®¶åãã«ãæ¥ã ã®è¡åã现èã¬ãã«ã§ã©ã圱é¿ããã®ãæŽçããŸãã
âæã®æ¥å·®ããæµŽã³ã
â äœå æèšãæŽããã³ã«ããŸãŒã«ãªãºã ãæ£åžžå â ççãšã¹ãã¬ã¹ãã«ã¢ã³ãé©åã«å¶åŸ¡ããã â å€ã®DNA修埩èœåãäžãã
âã¿ã³ãã¯è³ªã®æåéã確ä¿
玫å€ç·ãã¡ãŒãžããã®å埩ã«ã¯å€§éã®ã¢ããé žãå¿ èŠã ã»ãããªã³ ã»ãªãžã³ ã»ã°ãªã·ã³ ã»ã¢ã«ã®ãã³ ãããã¯ã³ã©ãŒã²ã³ã®äž»èŠæ§ææåã
âè¡ç³å€ã®å®å®å
é«è¡ç³ â AGEså¢å â ã³ã©ãŒã²ã³å£å â 玫å€ç·ãã¡ãŒãžå¢å¹ é£åŸè¡ç³ç®¡çã¯å èå察çãšããŠéåžžã«éèŠã
âé±2ã3åã®çãã¬
çèããåæ³ããããã€ãªã«ã€ã³ãããã³ã³ããªã¢ã掻æ§åããç®è修埩èœåãäžããã
âé©åºŠãªæ¥å 管ç
å®å šã«å€ªéœå ãæé€ããã®ã§ã¯ãªãã âã³ã³ãããŒã«ããã玫å€ç·åºæ¿âããã¿ãã³Dçæã«å¯äžã
ãã®ãã©ã³ã¹ããããå èåã«åŒ·ãèã¥ããã®æ¬è³ªã§ãã
å èåã«è² ããªãèã¯ãçæŽ»ã»éºäŒã»ä»£è¬ã®âç©ã¿äžãâã«ãã£ãŠäœããã
ãæ¥çŒãã«ããèããšã¯ãåã«ã¡ã©ãã³ãå€ãèã®ããšã§ã¯ãããŸããã ã»æé žåé µçŽ ãããåããŠãã ã»ççåå¿ãæŽèµ°ããªã ã»çްèèã匷ãæè» ã»ããã³ã³ããªã¢æ©èœãé«ã ã»è žå ç°å¢ãå®å®ããŠãã ã»ãã«ã¢ã³ãã©ã³ã¹ãæŽã£ãŠãã
ããããè€åçã«æŽã£ãç¶æ ãããã âå®ããèâïŒæ¬è³ªçã«åŒ·ãè ã§ãã
ã©ããã²ãšã€ã ãã§ã¯äžååã§ãéºäŒåã¿ã€ãã«åãããŠå šäœãæé©åããããšã§ãã¯ãããŠçŽ«å€ç·ãã¡ãŒãžãæå°åã§ããŸãã
ããŸãšãã
玫å€ç·ã«åŒ±ãâããçŒããèâã¯ãMC1Rãæé žåé µçŽ éºäŒåãªã©ã®åæ§ã«ãã£ãŠåœ±é¿ãåããŸãããäœè³ªã¯åŸå€©çãªã¢ãããŒãã§å€§ããå€ããããšãã§ããŸããéµãšãªãã®ã¯ãROSå¶åŸ¡ã»ççæå¶ã»ããã³ã³ããªã¢æŽ»æ§ã»è質ãã©ã³ã¹ã»è žå ç°å¢ãšãã5ã€ã®å çåºç€ããã¿ãã³Cãããªãã§ããŒã«ããªã¡ã¬3ãNrf2掻æ§åæåãã³ã©ãŒã²ã³çŽ æãæŠç¥çã«çµã¿åãããããšã§ã现è修埩åãšå é²åŸ¡åãåäžãâå®ããèâãžãšå€åããŸããæ¥ã ã®é£äºã»ç¡ç ã»éåã®ç©ã¿éããå èåã確å®ã«é ãããéµãšãªããŸãã